这是今天在微信里看到的

[向问天]

智利用了4种疫苗，有3种是西方的。

To date Chile has ordered close to 90 million vaccine doses – enough to fully vaccinate its population of 19.2 million people twice. It’s set to receive vaccines from Pfizer, AstraZeneca, Sinovac and Johnson & Johnson as well as from the global vaccine-supply programme, Covax.

Weiterleitungshinweis

 

[superlover]

让子弹飞会儿。

有疫苗肯定好一些，但绝对不会出现灭活疫苗更强于nRNA

 

[向问天]

智利 2021 April 2 的文章， 他们使用中国疫苗让他们比邻近的国家在抗疫方面更加成功。意思很明显，如果没有科兴疫苗，他们更惨。

Chile’s vaccination success and Paraguay’s failures are yet another illustration of how hard it is to draw general conclusions about health care responses to the pandemic.​

Chile’s vaccine procurement efforts, meanwhile, have been so successful that it has been criticized for hoarding. Unlike wealthier countries in North America and Europe, though, Chile placed a big bet on Sinovac’s shot, which many higher-income nations have avoided due to a lack of transparency about its efficacy. However, the World Health Organization recently stated that Sinovac’s vaccine shows levels of efficacy compatible with the agency’s requirements. Chile’s willingness to gamble on Sinovac’s shot gave it “a degree of access and priority that might have been tougher with big manufacturers like Pfizer and AstraZeneca,” as Vox’s Jen Kirby pointed out.

Like Chile, many other Latin American countries have turned to Chinese vaccines, having been mostly excluded from the scramble for Western ones. Seeking influence in the region, China—and Russia—have gladly filled the vaccine void. Opinion polls suggest that Latin Americans would prefer Western-made vaccines over Chinese or Russian shots, and Chileans are no exception. But the overwhelming sentiment is that Sinovac’s vaccine will save many lives. Soledad Martinez, a professor of public health at the University of Chile, told The Washington Post that health officials have been able to quell many concerns by pointing out that Sinovac also produces the flu shots that are administered across the country. “We were very adamant that you get the vaccine you’re offered,” she said.

The Lessons of Chile’s Vaccine Success—and Paraguay’s Struggles

Before a recent spike in COVID-19 cases, Chile was being lauded in the international press for its remarkable progress in vaccinating its population against the coronavirus. Soaring caseloads in recent weeks have dampened that narrative of success, but the fact remains that this small...

www.worldpoliticsreview.com

 

[woodwolf]

你说的没错，智利预定了多种疫苗，但收到的主要是科兴疫苗，所以智利对科兴疫苗具有指标性作用。我认为现在下结论还为时过早，一个月后再看结果吧。

 

[向问天]

等一个月没用，除非接种率超过80%。
现在中国疫苗太贵，他们买不起了。

 

[woodwolf]

等一个月没用，除非接种率超过80%。
现在中国疫苗太贵，他们买不起了。

辉瑞疫苗接种40%-50%已经显现出很好的防疫效果了。

 

[向问天]

辉瑞疫苗接种40%-50%已经显现出很好的防疫效果了。

瞎扯。
看看现在的Michigan。

 

[woodwolf]

瞎扯。
看看现在的Michigan。

浏览附件968235

任何事情都不能以点带面，综合分析以色列、英国和美国的趋势就可以得出结论。短期波动不可避免，所以我说要耐心再等等再下结论。

 

[向问天]

以色列的例子，接种率在30%到40%的时候，是感染率最高的时候。

 

[woodwolf]

这个已经有人指出了，看看昨天的讨论。

 

[向问天]

这个已经有人指出了，看看昨天的讨论。

没看到。
有我的提供的曲线显示得这么清楚吗？

 

[woodwolf]

没看到。
有我的提高的曲线显示得这么清楚吗？

有。所以我说不要忙于下结论说科兴疫苗效果不好。

 

[向问天]

有。所以我说不要忙于下结论说科兴疫苗效果不好。

你是对的。一些说中国疫苗不好的人基本都是自以为是的蠢货。他们自以为能从一堆烂数据中看出趋势。他们不考虑那些已经使用中国疫苗的国家为什么还要继续使用中国疫苗。如果效果不好，人家还要坚持使用？这不是侮辱人吗？南非发现阿斯利康对变异病毒效果不好，立即退货。据说这批退货后来被加拿大弄来了 。

 

[向问天]

辉瑞疫苗接种40%-50%已经显现出很好的防疫效果了。

任何事情都不能以点带面，综合分析以色列、英国和美国的趋势就可以得出结论。短期波动不可避免，所以我说要耐心再等等再下结论。

我反驳你的普遍性结论，只需要一个反例。